Human Cytomegalovirus-Encoded microRNAs Can Be Found in Saliva Samples from Renal Transplant Recipients

Human Cytomegalovirus-Encoded microRNAs Can Be Found in Saliva Samples from Renal Transplant Recipients

The human cytomegalovirus infection (HCMV) is general after kidney transplants and may have a long-term effect. HCMV can be measured directly by DNA virus or indirectly through the host of the immune response. Microrna encoded HCMV (MIRNA) can change the pathobiology of HCMV infection and contribute to the development of HCMV. MIRNAS encoded HCMV can be detected in the blood but has not been sought with saliva. We investigate the samples of saliva from 32 recipients of kidney transplant (RTR) and 12 seropositive health controls for whom immunological data is available.

Five Mirnas encoded HCMV (MIR-UL112-5P, MIR-US5-2-3P, MIR-UL36, MIR-US25-2-3P and MIR-UL22A) are searched using the primary probe test. HCMV Mirna species detected in saliva from 15 RTR and 3 healthy controls, with the most commonly detected MIR-US5-2-3P. The presence of HCMV MInnas is related to an increase in the T-cell response to HCMV IE-1 on RTR, shows a frequent reactive link from HCMV.

Cytomegalovirus endotheliitis after penetrating keratoplasty

Cytomegalovirus (CMV) – The chain corneal endothelial is the inflammation of the corneal endothelia caused by CMV. This can happen de novo or after ocular surgery in healthy individuals. In patients who have undergone Keratoplasty, the diagnosis of appealing viral endotheliitis and the rejection of the graft regarding the immune system challenges because of similar clinical findings.

Here we report a patient who underwent keratoplasty penetrating and using local and systemic immunosuppressive agents because of the history of the previous graft rejection. In the 4th postoperative, eye examination revealed local corneal edema, coin-shaped kereal deposits, and increased intraocular pressure, consistent with viral endotheliitis. The polymerase chain reaction reveals CMV-DNA amplification in aqueous humor sample. Valganciclovir treatment began and the symptoms improved in 2 months. It must be remembered that local or systemic immunosuppressants are used after keratoplasty can trigger CMV reactivation. Anti-CMV treatment must begin immediately in patients with coin-shaped keratic deposits.

Cytomegalovirus (CMV) management in alogenic hematopoietic cell transplants: Predictor pre-transplant survival, reactivation and spontaneous permits

Cytomegalovirus (CMV) reactivation is a complication that often occurs after alogenic hematopoietic cell transplants (ALLOHCT). We analyzed 159 ALLOHCT receivers with 4409 quantitative viral viral to determine the pre-transplanted predictor of CMV reactivation, clinically significant CMV infection (CS-CMVI, defined as Viral Load CMV> 1000 IU / ml), CMV disease, spontaneous cmv cleaning kinetics and survival Using a standard pre-emptive therapy approach to identify risk groups to target prevention strategies.

The most common CS-CMVI in non-related donor donor transplants (URD). Spontaneous CMV permits occurred in 26% of patients who reached Viral Load 56-137 IU / ML, 6% in 138-250 IU / ML and in 1 patient> 250 IU / ml. The median time between the first CMV reactivation (> 56 IU / ML) and Viral Load> 250 IU / ML is 13 days, while the time from the first viral load> 250 IU / ML to reach the Loading Vial> 1000 IU / ML 4 days. CS-CMVI is associated with a significant increase in non-relapse mortality (NRM) in multivariate analysis. Overall, this study shows that URD D / R + recipients are at high risk for mortality related CSVI and CMV, and are potential candidates for targeted CMV prophylaxis. CMV spontaneous cleaning outside the 250 IU / ML viral load is rare, indicating that this can be used as the appropriate threshold for starting pre-emptive therapy.

Human Cytomegalovirus-Encoded microRNAs Can Be Found in Saliva Samples from Renal Transplant Recipients

Cytomegalovirus-specific-specific-t-cell-specific-specific-cell receptor receptor after the alogenic stem cell transplantation

Cytomegalovirus (CMV) infection is the main complication during the alogenic stem cell transplantation (allo-sct). However, the mechanism of adaptive immunity which encourages this remains unclear. To define the initial immunological response against CMV after transplantation, we use the next generation sequencing to check the CD8 + / CMV Tetramer + cell (CMV-CCV) cell receptor (CMV-CTLS) in a peripheral blood sample obtained from 16 Allo-SCT receivers with HLA , -A * 24: 02 at the time of CMV reactivation.

In most patients, TCR Beta CMV-CTLS repertoar is very tilted (Median Inverse Simpson’s Index: 1,595) and, 15 of the 16 patients sharing at least one TCR-beta clone with ≥ 2 patients. TCR shared dominant in 12 patients and, two clonotypes were divided around half of the patients. The similarity analysis shows that CDR3 sequences from TCR together are more similar than TCR which is not divided. TCR beta repertoir from CMV-CTL in 12 patients was also analyzed after 2-4 weeks to characterize the short-term dynamics of the TCR repertoire. In ten patients, we observe the persistence of applicable clones. In two other patients, the TCR repertoire became more diverse, the main clone declined, and new private clones later emerged. These results provide substantive instructions to understand immunological behavior towards CMV reactivation after allo-sct.

Protein kinase autophagy-initiate ulk1 phosphorylation human cytomegalovirus tegument protein pp28 and regulate the release of an efficient virus

Autophagy is a catabolic process that contributes to intrinsic cellular defense by degrading viral or protein particles, but some viruses hijack this path for their own benefit. The role of autophagy during the replication of human cytomegalovirus (HCMV) has not been clarified earlier. Utilizing Sirna-based filtering, we observed that the depletion of many autophagy related proteins resulted in reduced virus releases showing the requirements of autophagy related factors for efficient HCMV replication.

In addition, we can show that the autophagy-initiation of Serine / Threonine-Protein Kinase ULK1 and other constituents of the UK1 complex have been regulated during the initial infection and remain regulated throughout the replication cycle. We show that indirect disturbances with ULK1 through the inhibition of the release of the UPSTRAM regulator regulator Virus Regulator. Furthermore, this result is verified by the direct revocation of Ulk1 Kinase activity that uses the Special Kinase Inhibitor Ulk1 SBI-0206965 and ULK-101.

Analysis of viral protein expression with the existence of an ULK-101 revealed the connection between the cellular kinase ULK1 and Viral Tegument Protein PP28 (Pul999) and we identified PP28 as a novel virus substrate with a vitro kinase test. In the absence of ulk1 kinase activity, a large PP28- and PP65-positive structure can be detected in the cytoplasm at the end point of the infection.

NFκB-p65 Antibody

B7163-100ul 100μl
EUR 217
Description: NFκB-p65 Rabbit Polyclonal Antibody

NFκB-p65 Antibody

B7163-50ul 50μl
EUR 143.5
Description: NFκB-p65 Rabbit Polyclonal Antibody

NFκB-p65 Antibody

B7169-100ul 100μl
EUR 217
Description: NFκB-p65 Rabbit Polyclonal Antibody

NFκB-p65 Antibody

B7169-50ul 50μl
EUR 143.5
Description: NFκB-p65 Rabbit Polyclonal Antibody

NFκB-p65 Antibody

B7170-100ul 100μl
EUR 217
Description: NFκB-p65 Rabbit Polyclonal Antibody

NFκB-p65 Antibody

B7170-50ul 50μl
EUR 143.5
Description: NFκB-p65 Rabbit Polyclonal Antibody

NFκB-p65 Antibody

B7171-100ul 100μl
EUR 217
Description: NFκB-p65 Rabbit Polyclonal Antibody

NFκB-p65 Antibody

B7171-50ul 50μl
EUR 143.5
Description: NFκB-p65 Rabbit Polyclonal Antibody

NFκB-p65 Antibody

B7172-100ul 100μl
EUR 217
Description: NFκB-p65 Rabbit Polyclonal Antibody

NFκB-p65 Antibody

B7172-50ul 50μl
EUR 143.5
Description: NFκB-p65 Rabbit Polyclonal Antibody

NFκB-p65 Antibody

B7173-100ul 100μl
EUR 217
Description: NFκB-p65 Rabbit Polyclonal Antibody

NFκB-p65 Antibody

B7173-50ul 50μl
EUR 143.5
Description: NFκB-p65 Rabbit Polyclonal Antibody

NFκB-p65 Antibody

B8049-100ul 100μl
EUR 217
Description: NFκB-p65 Rabbit Polyclonal Antibody

NFκB-p65 Antibody

B8049-50ul 50μl
EUR 143.5
Description: NFκB-p65 Rabbit Polyclonal Antibody

NFκB -p65 (Ab-435) Antibody

21012 100ul
EUR 319

NFκB -p65 (Ab-435) Antibody

21012-100ul 100ul
EUR 302.4

NFκB -p65 (Ab-435) Antibody

21012-50ul 50ul
EUR 224.4

NFκB -p65 (Ab-435) Antibody

E021012-1 50μg/50μl
EUR 100
Description: Available in various conjugation types.

NFκB -p65 (Ab-435) Antibody

E021012-2 100μg/100μl
EUR 170
Description: Available in various conjugation types.

NFκB p65 Mouse Monoclonal Antibody

38008 100ul
EUR 319

NFκB p65 Mouse Monoclonal Antibody

38008-100ul 100ul
EUR 302.4

NFκB p65 Mouse Monoclonal Antibody

38008-50ul 50ul
EUR 224.4

NFκB p65 Mouse Monoclonal Antibody

38054 100ul
EUR 319

NFκB p65 Mouse Monoclonal Antibody

38054-100ul 100ul
EUR 302.4

NFκB p65 Mouse Monoclonal Antibody

38054-50ul 50ul
EUR 224.4

NFκB p65 Mouse Monoclonal Antibody

E038008 100μg/100μl
EUR 255
Description: Available in various conjugation types.

NFκB p65 Mouse Monoclonal Antibody

E038054 100μg/100μl
EUR 255
Description: Available in various conjugation types.

NFκB p65 Mouse Monoclonal Antibody

E12-076 100μg/100μl
EUR 255
Description: Available in various conjugation types.

NFκB p65 Mouse Monoclonal Antibody

E12-138 100μg/100μl
EUR 225
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

ABP51952-100uL 100 μL
EUR 239
Description: Rabbit Anti-NFκB-p65 Polyclonal Antibody

NFκB-p65 Polyclonal Antibody

ABP51952-200uL 200 μL
EUR 379
Description: Rabbit Anti-NFκB-p65 Polyclonal Antibody

NFκB-p65 Polyclonal Antibody

ABP51952-30uL 30 μL
EUR 109
Description: Rabbit Anti-NFκB-p65 Polyclonal Antibody

NFκB-p65 Polyclonal Antibody

ABP0167-100uL 100 μL
EUR 229
Description: Rabbit Anti-NFκB-p65 Polyclonal Antibody

NFκB-p65 Polyclonal Antibody

41227-100ul 100ul
EUR 302.4

NFκB-p65 Polyclonal Antibody

41227-50ul 50ul
EUR 224.4

NFκB-p65 Polyclonal Antibody

41228 100ul
EUR 319

NFκB-p65 Polyclonal Antibody

41228-100ul 100ul
EUR 302.4

NFκB-p65 Polyclonal Antibody

41228-50ul 50ul
EUR 224.4

NFκB-p65 Polyclonal Antibody

41229-100ul 100ul
EUR 302.4

NFκB-p65 Polyclonal Antibody

41229-50ul 50ul
EUR 224.4

NFκB-p65 Polyclonal Antibody

41230-100ul 100ul
EUR 302.4

NFκB-p65 Polyclonal Antibody

41230-50ul 50ul
EUR 224.4

NFκB-p65 Polyclonal Antibody

41231-100ul 100ul
EUR 302.4

NFκB-p65 Polyclonal Antibody

41231-50ul 50ul
EUR 224.4

NFκB-p65 Polyclonal Antibody

41232-100ul 100ul
EUR 302.4

NFκB-p65 Polyclonal Antibody

41232-50ul 50ul
EUR 224.4

NFκB-p65 Polyclonal Antibody

41233-100ul 100ul
EUR 302.4

NFκB-p65 Polyclonal Antibody

41233-50ul 50ul
EUR 224.4

NFκB-p65 Polyclonal Antibody

41234-100ul 100ul
EUR 302.4

NFκB-p65 Polyclonal Antibody

41234-50ul 50ul
EUR 224.4

NFκB-p65 Polyclonal Antibody

41235-100ul 100ul
EUR 302.4

NFκB-p65 Polyclonal Antibody

41235-50ul 50ul
EUR 224.4

NFκB-p65 Polyclonal Antibody

41236-100ul 100ul
EUR 302.4

NFκB-p65 Polyclonal Antibody

41236-50ul 50ul
EUR 224.4

NFκB-p65 Polyclonal Antibody

41237-100ul 100ul
EUR 302.4

NFκB-p65 Polyclonal Antibody

41237-50ul 50ul
EUR 224.4

NFκB-p65 Polyclonal Antibody

41732-100ul 100ul
EUR 302.4

NFκB-p65 Polyclonal Antibody

41732-50ul 50ul
EUR 224.4

NFκB-p65 Polyclonal Antibody

41733-100ul 100ul
EUR 302.4

NFκB-p65 Polyclonal Antibody

41733-50ul 50ul
EUR 224.4

NFκB-p65 Polyclonal Antibody

41808-100ul 100ul
EUR 302.4

NFκB-p65 Polyclonal Antibody

41808-50ul 50ul
EUR 224.4

NFκB-p65 Polyclonal Antibody

E041227 100μg/100μl
EUR 255
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E041228 100μg/100μl
EUR 255
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E041229 100μg/100μl
EUR 255
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E041230 100μg/100μl
EUR 255
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E041231 100μg/100μl
EUR 255
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E041232 100μg/100μl
EUR 255
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E041233 100μg/100μl
EUR 255
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E041234 100μg/100μl
EUR 255
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E041235 100μg/100μl
EUR 255
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E041236 100μg/100μl
EUR 255
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E041237 100μg/100μl
EUR 255
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E041732 100μg/100μl
EUR 255
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E041733 100μg/100μl
EUR 255
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E041808 100μg/100μl
EUR 255
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E20-75338 100ug
EUR 225
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E20-75339 100ug
EUR 225
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E20-75428 100ug
EUR 225
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E20-73102 100ug
EUR 225
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E20-73103 100ug
EUR 225
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E20-73104 100ug
EUR 225
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E20-73105 100ug
EUR 225
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E20-73106 100ug
EUR 225
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E20-73107 100ug
EUR 225
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E20-73108 100ug
EUR 225
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E20-73109 100ug
EUR 225
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E20-73110 100ug
EUR 225
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E20-73111 100ug
EUR 225
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

E20-73112 100ug
EUR 225
Description: Available in various conjugation types.

NFκB-p65 Polyclonal Antibody

ABP0167-each each Ask for price

NFκB-p65 Polyclonal Antibody

ABP0167-Null Null Ask for price

NFκB-p65 Polyclonal Antibody

E-AB-14244-120uL 120uL
EUR 240
Description: Unconjugated

NFκB-p65 Polyclonal Antibody

E-AB-14244-200uL 200uL
EUR 399
Description: Unconjugated

NFκB-p65 Polyclonal Antibody

E-AB-14244-20uL 20uL
EUR 73
Description: Unconjugated

NFκB-p65 Polyclonal Antibody

E-AB-14244-60uL 60uL
EUR 143
Description: Unconjugated

NFκB-p65 Polyclonal Antibody

E44H05472 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

NFκB-p65 Polyclonal Antibody

E44H05473 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

NFκB-p65 Polyclonal Antibody

E44H06780 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

NFκB-p65 Polyclonal Antibody

E44H06781 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

NFκB-p65 Polyclonal Antibody

E44H06870 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

NFκB-p65 Polyclonal Antibody

E44H03265 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

NFκB-p65 Polyclonal Antibody

E44H03266 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

NFκB-p65 Polyclonal Antibody

E44H03267 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

NFκB-p65 Polyclonal Antibody

E44H03268 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

NFκB-p65 Polyclonal Antibody

E44H03269 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

NFκB-p65 Polyclonal Antibody

E44H03270 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

NFκB-p65 Polyclonal Antibody

E44H03271 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

NFκB-p65 Polyclonal Antibody

E44H03272 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

NFκB-p65 Polyclonal Antibody

E44H03273 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

NFκB-p65 Polyclonal Antibody

E-AB-32233-120uL 120uL
EUR 240
Description: Unconjugated

NFκB-p65 Polyclonal Antibody

E-AB-32233-200uL 200uL
EUR 399
Description: Unconjugated

NFκB-p65 Polyclonal Antibody

E-AB-32233-20uL 20uL
EUR 73
Description: Unconjugated

NFκB-p65 Polyclonal Antibody

E-AB-32233-60uL 60uL
EUR 143
Description: Unconjugated

NFκB-p65 Monoclonal Antibody

E-AB-22016-120uL 120uL
EUR 240
Description: Unconjugated

NFκB-p65 Monoclonal Antibody

E-AB-22016-200uL 200uL
EUR 399
Description: Unconjugated

NFκB-p65 Monoclonal Antibody

E-AB-22016-20uL 20uL
EUR 73
Description: Unconjugated

NFκB-p65 Monoclonal Antibody

E-AB-22016-60uL 60uL
EUR 143
Description: Unconjugated

NFκB-p65 Monoclonal Antibody

E-AB-22066-120uL 120uL
EUR 240
Description: Unconjugated

NFκB-p65 Monoclonal Antibody

E-AB-22066-200uL 200uL
EUR 399
Description: Unconjugated

NFκB-p65 Monoclonal Antibody

E-AB-22066-20uL 20uL
EUR 73
Description: Unconjugated

NFκB-p65 Monoclonal Antibody

E-AB-22066-60uL 60uL
EUR 143
Description: Unconjugated

NFκB-p65 Monoclonal Antibody

RD85474A-120uL 120μL
EUR 360
Description: Proteins encoded by the v-Rel viral oncogene and its cellular homolog, c-Rel,are members of a family of transcription factors that include the two subunits of the transcription factor NFκB (p50 and p65) and the Drosophila maternal morphogen, dorsal. Both proteins specifically bind to DNA sequences that are the same or slight variations of the 10 bp κB sequence in the immunoglobulin κ light chain enhancer. This same sequence is also present in a number of other cellular and viral enhancers. The DNA binding activity of NFκB is activated and NFκB is subsequently transported from the cytoplasm to the nucleus in cells exposed to mitogens or growth factors. cDNAs encoding precursors for two distinct proteins of the same size have been described, designated p105 and p100. The p105 precursor contains p50 at its N-terminus and a C-terminal region that when expressed as a separate molecule, designated pdI, binds to p50 and regulates its activity.

NFκB-p65 Monoclonal Antibody

RD85474A-200uL 200μL
EUR 630
Description: Proteins encoded by the v-Rel viral oncogene and its cellular homolog, c-Rel,are members of a family of transcription factors that include the two subunits of the transcription factor NFκB (p50 and p65) and the Drosophila maternal morphogen, dorsal. Both proteins specifically bind to DNA sequences that are the same or slight variations of the 10 bp κB sequence in the immunoglobulin κ light chain enhancer. This same sequence is also present in a number of other cellular and viral enhancers. The DNA binding activity of NFκB is activated and NFκB is subsequently transported from the cytoplasm to the nucleus in cells exposed to mitogens or growth factors. cDNAs encoding precursors for two distinct proteins of the same size have been described, designated p105 and p100. The p105 precursor contains p50 at its N-terminus and a C-terminal region that when expressed as a separate molecule, designated pdI, binds to p50 and regulates its activity.

NFκB-p65 Monoclonal Antibody

RD85474A-20uL 20μL
EUR 109.5
Description: Proteins encoded by the v-Rel viral oncogene and its cellular homolog, c-Rel,are members of a family of transcription factors that include the two subunits of the transcription factor NFκB (p50 and p65) and the Drosophila maternal morphogen, dorsal. Both proteins specifically bind to DNA sequences that are the same or slight variations of the 10 bp κB sequence in the immunoglobulin κ light chain enhancer. This same sequence is also present in a number of other cellular and viral enhancers. The DNA binding activity of NFκB is activated and NFκB is subsequently transported from the cytoplasm to the nucleus in cells exposed to mitogens or growth factors. cDNAs encoding precursors for two distinct proteins of the same size have been described, designated p105 and p100. The p105 precursor contains p50 at its N-terminus and a C-terminal region that when expressed as a separate molecule, designated pdI, binds to p50 and regulates its activity.

NFκB-p65 Monoclonal Antibody

RD85474A-60uL 60μL
EUR 214.5
Description: Proteins encoded by the v-Rel viral oncogene and its cellular homolog, c-Rel,are members of a family of transcription factors that include the two subunits of the transcription factor NFκB (p50 and p65) and the Drosophila maternal morphogen, dorsal. Both proteins specifically bind to DNA sequences that are the same or slight variations of the 10 bp κB sequence in the immunoglobulin κ light chain enhancer. This same sequence is also present in a number of other cellular and viral enhancers. The DNA binding activity of NFκB is activated and NFκB is subsequently transported from the cytoplasm to the nucleus in cells exposed to mitogens or growth factors. cDNAs encoding precursors for two distinct proteins of the same size have been described, designated p105 and p100. The p105 precursor contains p50 at its N-terminus and a C-terminal region that when expressed as a separate molecule, designated pdI, binds to p50 and regulates its activity.

NFκB-p65 Monoclonal Antibody

RD85577A-120uL 120μL
EUR 360
Description: Proteins encoded by the v-Rel viral oncogene and its cellular homolog, c-Rel,are members of a family of transcription factors that include the two subunits of the transcription factor NFκB (p50 and p65) and the Drosophila maternal morphogen, dorsal. Both proteins specifically bind to DNA sequences that are the same or slight variations of the 10 bp κB sequence in the immunoglobulin κ light chain enhancer. This same sequence is also present in a number of other cellular and viral enhancers. The DNA binding activity of NFκB is activated and NFκB is subsequently transported from the cytoplasm to the nucleus in cells exposed to mitogens or growth factors. cDNAs encoding precursors for two distinct proteins of the same size have been described, designated p105 and p100. The p105 precursor contains p50 at its N-terminus and a C-terminal region that when expressed as a separate molecule, designated pdI, binds to p50 and regulates its activity.

NFκB-p65 Monoclonal Antibody

RD85577A-200uL 200μL
EUR 630
Description: Proteins encoded by the v-Rel viral oncogene and its cellular homolog, c-Rel,are members of a family of transcription factors that include the two subunits of the transcription factor NFκB (p50 and p65) and the Drosophila maternal morphogen, dorsal. Both proteins specifically bind to DNA sequences that are the same or slight variations of the 10 bp κB sequence in the immunoglobulin κ light chain enhancer. This same sequence is also present in a number of other cellular and viral enhancers. The DNA binding activity of NFκB is activated and NFκB is subsequently transported from the cytoplasm to the nucleus in cells exposed to mitogens or growth factors. cDNAs encoding precursors for two distinct proteins of the same size have been described, designated p105 and p100. The p105 precursor contains p50 at its N-terminus and a C-terminal region that when expressed as a separate molecule, designated pdI, binds to p50 and regulates its activity.

NFκB-p65 Monoclonal Antibody

RD85577A-20uL 20μL
EUR 109.5
Description: Proteins encoded by the v-Rel viral oncogene and its cellular homolog, c-Rel,are members of a family of transcription factors that include the two subunits of the transcription factor NFκB (p50 and p65) and the Drosophila maternal morphogen, dorsal. Both proteins specifically bind to DNA sequences that are the same or slight variations of the 10 bp κB sequence in the immunoglobulin κ light chain enhancer. This same sequence is also present in a number of other cellular and viral enhancers. The DNA binding activity of NFκB is activated and NFκB is subsequently transported from the cytoplasm to the nucleus in cells exposed to mitogens or growth factors. cDNAs encoding precursors for two distinct proteins of the same size have been described, designated p105 and p100. The p105 precursor contains p50 at its N-terminus and a C-terminal region that when expressed as a separate molecule, designated pdI, binds to p50 and regulates its activity.

NFκB-p65 Monoclonal Antibody

RD85577A-60uL 60μL
EUR 214.5
Description: Proteins encoded by the v-Rel viral oncogene and its cellular homolog, c-Rel,are members of a family of transcription factors that include the two subunits of the transcription factor NFκB (p50 and p65) and the Drosophila maternal morphogen, dorsal. Both proteins specifically bind to DNA sequences that are the same or slight variations of the 10 bp κB sequence in the immunoglobulin κ light chain enhancer. This same sequence is also present in a number of other cellular and viral enhancers. The DNA binding activity of NFκB is activated and NFκB is subsequently transported from the cytoplasm to the nucleus in cells exposed to mitogens or growth factors. cDNAs encoding precursors for two distinct proteins of the same size have been described, designated p105 and p100. The p105 precursor contains p50 at its N-terminus and a C-terminal region that when expressed as a separate molecule, designated pdI, binds to p50 and regulates its activity.

NFκB-p65 Polyclonal Antibody

RD77528A-120uL 120μL
EUR 360
Description: NF-kappa-B is a ubiquitous transcription factor involved in several biological processes. It is held in the cytoplasm in an inactive state by specific inhibitors. Upon degradation of the inhibitor, NF-kappa-B moves to the nucleus and activates transcription of specific genes. NF-kappa-B is composed of NFKB1 or NFKB2 bound to either REL, RELA, or RELB. The most abundant form of NF-kappa-B is NFKB1 complexed with the product of this gene, RELA. Four transcript variants encoding different isoforms have been found for this gene.

NFκB-p65 Polyclonal Antibody

RD77528A-200uL 200μL
EUR 630
Description: NF-kappa-B is a ubiquitous transcription factor involved in several biological processes. It is held in the cytoplasm in an inactive state by specific inhibitors. Upon degradation of the inhibitor, NF-kappa-B moves to the nucleus and activates transcription of specific genes. NF-kappa-B is composed of NFKB1 or NFKB2 bound to either REL, RELA, or RELB. The most abundant form of NF-kappa-B is NFKB1 complexed with the product of this gene, RELA. Four transcript variants encoding different isoforms have been found for this gene.

NFκB-p65 Polyclonal Antibody

RD77528A-20uL 20μL
EUR 109.5
Description: NF-kappa-B is a ubiquitous transcription factor involved in several biological processes. It is held in the cytoplasm in an inactive state by specific inhibitors. Upon degradation of the inhibitor, NF-kappa-B moves to the nucleus and activates transcription of specific genes. NF-kappa-B is composed of NFKB1 or NFKB2 bound to either REL, RELA, or RELB. The most abundant form of NF-kappa-B is NFKB1 complexed with the product of this gene, RELA. Four transcript variants encoding different isoforms have been found for this gene.

NFκB-p65 Polyclonal Antibody

RD77528A-60uL 60μL
EUR 214.5
Description: NF-kappa-B is a ubiquitous transcription factor involved in several biological processes. It is held in the cytoplasm in an inactive state by specific inhibitors. Upon degradation of the inhibitor, NF-kappa-B moves to the nucleus and activates transcription of specific genes. NF-kappa-B is composed of NFKB1 or NFKB2 bound to either REL, RELA, or RELB. The most abundant form of NF-kappa-B is NFKB1 complexed with the product of this gene, RELA. Four transcript variants encoding different isoforms have been found for this gene.

NFκB-p65 Polyclonal Antibody

RD232232A-120uL 120μL
EUR 360
Description: Proteins encoded by the v-Rel viral oncogene and its cellular homolog, c-Rel,are members of a family of transcription factors that include the two subunits of the transcription factor NFκB (p50 and p65) and the Drosophila maternal morphogen, dorsal. Both proteins specifically bind to DNA sequences that are the same or slight variations of the 10 bp κB sequence in the immunoglobulin κ light chain enhancer. This same sequence is also present in a number of other cellular and viral enhancers. The DNA binding activity of NFκB is activated and NFκB is subsequently transported from the cytoplasm to the nucleus in cells exposed to mitogens or growth factors. cDNAs encoding precursors for two distinct proteins of the same size have been described, designated p105 and p100. The p105 precursor contains p50 at its N-terminus and a C-terminal region that when expressed as a separate molecule, designated pdI, binds to p50 and regulates its activity.

NFκB-p65 Polyclonal Antibody

RD232232A-200uL 200μL
EUR 630
Description: Proteins encoded by the v-Rel viral oncogene and its cellular homolog, c-Rel,are members of a family of transcription factors that include the two subunits of the transcription factor NFκB (p50 and p65) and the Drosophila maternal morphogen, dorsal. Both proteins specifically bind to DNA sequences that are the same or slight variations of the 10 bp κB sequence in the immunoglobulin κ light chain enhancer. This same sequence is also present in a number of other cellular and viral enhancers. The DNA binding activity of NFκB is activated and NFκB is subsequently transported from the cytoplasm to the nucleus in cells exposed to mitogens or growth factors. cDNAs encoding precursors for two distinct proteins of the same size have been described, designated p105 and p100. The p105 precursor contains p50 at its N-terminus and a C-terminal region that when expressed as a separate molecule, designated pdI, binds to p50 and regulates its activity.

NFκB-p65 Polyclonal Antibody

RD232232A-20uL 20μL
EUR 109.5
Description: Proteins encoded by the v-Rel viral oncogene and its cellular homolog, c-Rel,are members of a family of transcription factors that include the two subunits of the transcription factor NFκB (p50 and p65) and the Drosophila maternal morphogen, dorsal. Both proteins specifically bind to DNA sequences that are the same or slight variations of the 10 bp κB sequence in the immunoglobulin κ light chain enhancer. This same sequence is also present in a number of other cellular and viral enhancers. The DNA binding activity of NFκB is activated and NFκB is subsequently transported from the cytoplasm to the nucleus in cells exposed to mitogens or growth factors. cDNAs encoding precursors for two distinct proteins of the same size have been described, designated p105 and p100. The p105 precursor contains p50 at its N-terminus and a C-terminal region that when expressed as a separate molecule, designated pdI, binds to p50 and regulates its activity.

NFκB-p65 Polyclonal Antibody

RD232232A-60uL 60μL
EUR 214.5
Description: Proteins encoded by the v-Rel viral oncogene and its cellular homolog, c-Rel,are members of a family of transcription factors that include the two subunits of the transcription factor NFκB (p50 and p65) and the Drosophila maternal morphogen, dorsal. Both proteins specifically bind to DNA sequences that are the same or slight variations of the 10 bp κB sequence in the immunoglobulin κ light chain enhancer. This same sequence is also present in a number of other cellular and viral enhancers. The DNA binding activity of NFκB is activated and NFκB is subsequently transported from the cytoplasm to the nucleus in cells exposed to mitogens or growth factors. cDNAs encoding precursors for two distinct proteins of the same size have been described, designated p105 and p100. The p105 precursor contains p50 at its N-terminus and a C-terminal region that when expressed as a separate molecule, designated pdI, binds to p50 and regulates its activity.

NFκB-p65 Polyclonal Antibody

RD70208A-120uL 120μL
EUR 345
Description: NF-kappa-B is a ubiquitous transcription factor involved in several biological processes. It is held in the cytoplasm in an inactive state by specific inhibitors. Upon degradation of the inhibitor, NF-kappa-B moves to the nucleus and activates transcription of specific genes. NF-kappa-B is composed of NFKB1 or NFKB2 bound to either REL, RELA, or RELB. The most abundant form of NF-kappa-B is NFKB1 complexed with the product of this gene, RELA. Four transcript variants encoding different isoforms have been found for this gene.

NFκB-p65 Polyclonal Antibody

RD70208A-200uL 200μL
EUR 570
Description: NF-kappa-B is a ubiquitous transcription factor involved in several biological processes. It is held in the cytoplasm in an inactive state by specific inhibitors. Upon degradation of the inhibitor, NF-kappa-B moves to the nucleus and activates transcription of specific genes. NF-kappa-B is composed of NFKB1 or NFKB2 bound to either REL, RELA, or RELB. The most abundant form of NF-kappa-B is NFKB1 complexed with the product of this gene, RELA. Four transcript variants encoding different isoforms have been found for this gene.

NFκB-p65 Polyclonal Antibody

RD70208A-20uL 20μL
EUR 97.5
Description: NF-kappa-B is a ubiquitous transcription factor involved in several biological processes. It is held in the cytoplasm in an inactive state by specific inhibitors. Upon degradation of the inhibitor, NF-kappa-B moves to the nucleus and activates transcription of specific genes. NF-kappa-B is composed of NFKB1 or NFKB2 bound to either REL, RELA, or RELB. The most abundant form of NF-kappa-B is NFKB1 complexed with the product of this gene, RELA. Four transcript variants encoding different isoforms have been found for this gene.

NFκB-p65 Polyclonal Antibody

RD70208A-60uL 60μL
EUR 187.5
Description: NF-kappa-B is a ubiquitous transcription factor involved in several biological processes. It is held in the cytoplasm in an inactive state by specific inhibitors. Upon degradation of the inhibitor, NF-kappa-B moves to the nucleus and activates transcription of specific genes. NF-kappa-B is composed of NFKB1 or NFKB2 bound to either REL, RELA, or RELB. The most abundant form of NF-kappa-B is NFKB1 complexed with the product of this gene, RELA. Four transcript variants encoding different isoforms have been found for this gene.

NFκB-p65 Polyclonal Antibody

RD72721A-120uL 120μL
EUR 360
Description: Proteins encoded by the v-Rel viral oncogene and its cellular homolog, c-Rel,are members of a family of transcription factors that include the two subunits of the transcription factor NFκB (p50 and p65) and the Drosophila maternal morphogen, dorsal. Both proteins specifically bind to DNA sequences that are the same or slight variations of the 10 bp κB sequence in the immunoglobulin κ light chain enhancer. This same sequence is also present in a number of other cellular and viral enhancers. The DNA binding activity of NFκB is activated and NFκB is subsequently transported from the cytoplasm to the nucleus in cells exposed to mitogens or growth factors. cDNAs encoding precursors for two distinct proteins of the same size have been described, designated p105 and p100. The p105 precursor contains p50 at its N-terminus and a C-terminal region that when expressed as a separate molecule, designated pdI, binds to p50 and regulates its activity.

NFκB-p65 Polyclonal Antibody

RD72721A-200uL 200μL
EUR 630
Description: Proteins encoded by the v-Rel viral oncogene and its cellular homolog, c-Rel,are members of a family of transcription factors that include the two subunits of the transcription factor NFκB (p50 and p65) and the Drosophila maternal morphogen, dorsal. Both proteins specifically bind to DNA sequences that are the same or slight variations of the 10 bp κB sequence in the immunoglobulin κ light chain enhancer. This same sequence is also present in a number of other cellular and viral enhancers. The DNA binding activity of NFκB is activated and NFκB is subsequently transported from the cytoplasm to the nucleus in cells exposed to mitogens or growth factors. cDNAs encoding precursors for two distinct proteins of the same size have been described, designated p105 and p100. The p105 precursor contains p50 at its N-terminus and a C-terminal region that when expressed as a separate molecule, designated pdI, binds to p50 and regulates its activity.

NFκB-p65 Polyclonal Antibody

RD72721A-20uL 20μL
EUR 109.5
Description: Proteins encoded by the v-Rel viral oncogene and its cellular homolog, c-Rel,are members of a family of transcription factors that include the two subunits of the transcription factor NFκB (p50 and p65) and the Drosophila maternal morphogen, dorsal. Both proteins specifically bind to DNA sequences that are the same or slight variations of the 10 bp κB sequence in the immunoglobulin κ light chain enhancer. This same sequence is also present in a number of other cellular and viral enhancers. The DNA binding activity of NFκB is activated and NFκB is subsequently transported from the cytoplasm to the nucleus in cells exposed to mitogens or growth factors. cDNAs encoding precursors for two distinct proteins of the same size have been described, designated p105 and p100. The p105 precursor contains p50 at its N-terminus and a C-terminal region that when expressed as a separate molecule, designated pdI, binds to p50 and regulates its activity.

NFκB-p65 Polyclonal Antibody

RD72721A-60uL 60μL
EUR 214.5
Description: Proteins encoded by the v-Rel viral oncogene and its cellular homolog, c-Rel,are members of a family of transcription factors that include the two subunits of the transcription factor NFκB (p50 and p65) and the Drosophila maternal morphogen, dorsal. Both proteins specifically bind to DNA sequences that are the same or slight variations of the 10 bp κB sequence in the immunoglobulin κ light chain enhancer. This same sequence is also present in a number of other cellular and viral enhancers. The DNA binding activity of NFκB is activated and NFκB is subsequently transported from the cytoplasm to the nucleus in cells exposed to mitogens or growth factors. cDNAs encoding precursors for two distinct proteins of the same size have been described, designated p105 and p100. The p105 precursor contains p50 at its N-terminus and a C-terminal region that when expressed as a separate molecule, designated pdI, binds to p50 and regulates its activity.

NFκB -p65 (Ab-435) Conjugated Antibody

C21012 100ul
EUR 476.4

NFκB p65 Mouse Monoclonal Antibody(5G6)

RA10386-100ul 100 ul
EUR 298

NFκB p65 Mouse Monoclonal Antibody(5G6)

RA10386-50ul 50 ul
EUR 198

NFκB-p65 (Ab-254) Antibody

21010 100ul
EUR 319

NFκB-p65 (Ab-254) Antibody

21010-100ul 100ul
EUR 302.4

NFκB-p65 (Ab-254) Antibody

21010-50ul 50ul
EUR 224.4

NFκB-p65 (Ab-276) Antibody

21011 100ul
EUR 319

NFκB-p65 (Ab-276) Antibody

21011-100ul 100ul
EUR 302.4

NFκB-p65 (Ab-276) Antibody

21011-50ul 50ul
EUR 224.4

NFκB-p65 (Ab-468) Antibody

21013 100ul
EUR 319

NFκB-p65 (Ab-468) Antibody

21013-100ul 100ul
EUR 302.4

NFκB-p65 (Ab-468) Antibody

21013-50ul 50ul
EUR 224.4

NFκB-p65 (Ab-536) Antibody

21014 100ul
EUR 319

NFκB-p65 (Ab-536) Antibody

21014-100ul 100ul
EUR 302.4

NFκB-p65 (Ab-536) Antibody

21014-50ul 50ul
EUR 224.4

NFκB-p65 (Ab-505) Antibody

21178-100ul 100ul
EUR 302.4

NFκB-p65 (Ab-505) Antibody

21178-50ul 50ul
EUR 224.4

NFκB-p65 (Ab-529) Antibody

21210-100ul 100ul
EUR 302.4

NFκB-p65 (Ab-529) Antibody

21210-50ul 50ul
EUR 224.4

NFκB-p65 (Ab-311) Antibody

21252 100ul
EUR 319

NFκB-p65 (Ab-311) Antibody

21252-100ul 100ul
EUR 302.4

NFκB-p65 (Ab-311) Antibody

21252-50ul 50ul
EUR 224.4

NFκB-p65 (Ab-254) Antibody

E021010-1 50μg/50μl
EUR 100
Description: Available in various conjugation types.

NFκB-p65 (Ab-254) Antibody

E021010-2 100μg/100μl
EUR 170
Description: Available in various conjugation types.

NFκB-p65 (Ab-276) Antibody

E021011-1 50μg/50μl
EUR 100
Description: Available in various conjugation types.

NFκB-p65 (Ab-276) Antibody

E021011-2 100μg/100μl
EUR 170
Description: Available in various conjugation types.

NFκB-p65 (Ab-468) Antibody

E021013-1 50μg/50μl
EUR 100
Description: Available in various conjugation types.

NFκB-p65 (Ab-468) Antibody

E021013-2 100μg/100μl
EUR 170
Description: Available in various conjugation types.

NFκB-p65 (Ab-536) Antibody

E021014-1 50μg/50μl
EUR 100
Description: Available in various conjugation types.

NFκB-p65 (Ab-536) Antibody

E021014-2 100μg/100μl
EUR 170
Description: Available in various conjugation types.

NFκB-p65 (Ab-505) Antibody

E021178-1 50μg/50μl
EUR 100
Description: Available in various conjugation types.

NFκB-p65 (Ab-505) Antibody

E021178-2 100μg/100μl
EUR 170
Description: Available in various conjugation types.

NFκB-p65 (Ab-529) Antibody

E021210-1 50μg/50μl
EUR 100
Description: Available in various conjugation types.

NFκB-p65 (Ab-529) Antibody

E021210-2 100μg/100μl
EUR 170
Description: Available in various conjugation types.

NFκB-p65 (Ab-311) Antibody

E021252-1 50μg/50μl
EUR 100
Description: Available in various conjugation types.

NFκB-p65 (Ab-311) Antibody

E021252-2 100μg/100μl
EUR 170
Description: Available in various conjugation types.

NFκB-p65 (Acetyl-Lys310) Antibody

D0018-100ul 100μl
EUR 217
Description: NFκB-p65 (Acetyl-Lys310) Rabbit Polyclonal Antibody

NFκB-p65 (Acetyl-Lys310) Antibody

D0018-50ul 50μl
EUR 143.5
Description: NFκB-p65 (Acetyl-Lys310) Rabbit Polyclonal Antibody

NFκB-p65 (Acetyl-Lys122) Antibody

D12159-100ul 100μl
EUR 217
Description: NFκB-p65 (Acetyl-Lys122) Rabbit Polyclonal Antibody

NFκB-p65 (Acetyl-Lys122) Antibody

D12159-50ul 50μl
EUR 143.5
Description: NFκB-p65 (Acetyl-Lys122) Rabbit Polyclonal Antibody

NFκB-p65 (Acetyl-Lys218) Antibody

D12160-100ul 100μl
EUR 217
Description: NFκB-p65 (Acetyl-Lys218) Rabbit Polyclonal Antibody

NFκB-p65 (Acetyl-Lys218) Antibody

D12160-50ul 50μl
EUR 143.5
Description: NFκB-p65 (Acetyl-Lys218) Rabbit Polyclonal Antibody

Electron transmission microscope shows that this structure represents the accumulation of large perinuclear proteins that may represent agresom. Our results show that HCMV manipulated UK1 and further components of the autophagic machine to ensure efficient virus particle release.

Leave A Comment